A detailed history of Argyle Capital Management Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Argyle Capital Management Inc. holds 34,050 shares of MDT stock, worth $2.94 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
34,050
Previous 36,320 6.25%
Holding current value
$2.94 Million
Previous $2.86 Million 7.24%
% of portfolio
1.24%
Previous 1.19%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$76.84 - $91.03 $174,426 - $206,638
-2,270 Reduced 6.25%
34,050 $3.07 Million
Q2 2024

Jul 29, 2024

SELL
$78.71 - $87.02 $125,935 - $139,232
-1,600 Reduced 4.22%
36,320 $2.86 Million
Q1 2024

Apr 29, 2024

SELL
$82.84 - $88.09 $165,680 - $176,180
-2,000 Reduced 5.01%
37,920 $3.3 Million
Q4 2023

Feb 05, 2024

SELL
$69.43 - $83.43 $517,253 - $621,553
-7,450 Reduced 15.73%
39,920 $3.29 Million
Q3 2023

Oct 26, 2023

BUY
$78.22 - $90.4 $117,330 - $135,600
1,500 Added 3.27%
47,370 $3.71 Million
Q2 2023

Jul 27, 2023

SELL
$79.47 - $91.38 $47,682 - $54,828
-600 Reduced 1.29%
45,870 $4.04 Million
Q1 2023

Apr 27, 2023

BUY
$76.72 - $87.58 $299,208 - $341,562
3,900 Added 9.16%
46,470 $3.75 Million
Q3 2022

Oct 21, 2022

BUY
$80.75 - $95.31 $62,177 - $73,388
770 Added 1.84%
42,570 $3.44 Million
Q2 2022

Jul 20, 2022

BUY
$87.4 - $113.09 $34,960 - $45,236
400 Added 0.97%
41,800 $3.75 Million
Q1 2022

Apr 27, 2022

SELL
$100.58 - $112.38 $211,218 - $235,998
-2,100 Reduced 4.83%
41,400 $4.59 Million
Q4 2021

Jan 25, 2022

BUY
$99.53 - $127.75 $4.33 Million - $5.56 Million
43,500 New
43,500 $4.5 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Argyle Capital Management Inc. Portfolio

Follow Argyle Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.